Product
Lipoic acid
2 clinical trials
3 indications
Indication
Diabetes MellitusIndication
Type 2Indication
Multiple SclerosisClinical trial
The Effects of Lipoic Acid on Glycaemic Control in Type 2 DiabetesStatus: Withdrawn, Estimated PCD: 2011-01-01
Clinical trial
Lipoic Acid for the Treatment of Progressive Multiple SclerosisStatus: Active (not recruiting), Estimated PCD: 2023-12-31